Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis

Author:

Parvizi Sanaz1ORCID,Mehrara Mohsen1,Taiebnia Ali1

Affiliation:

1. Faculty of economics University of Tehran Tehran Iran

Abstract

AbstractBackground and AimsThis study aimed to estimate the preferences for COVID‐19 vaccines among a sample of Iranian adults and to understand the sources of preference heterogeneity.MethodsA web‐based survey was conducted from April to July 2021; out of 1747 participants, 678 completed the survey. Seven key attributes were selected, namely effectiveness, risk of severe side effects, risk of mild side effects, number of doses, duration of protection, location of manufacture, and price. Additionally, conditional logit and mixed logit models were used to analyze the data.ResultsThe results of this study indicate that vaccine effectiveness, protective duration, the risk of side effects, and price are the most important factors that influence vaccine preferences. Furthermore, we identified heterogeneity in preferences, indicating that not all individuals respond in the same way to vaccine attributes.ConclusionThe majority of Iranians prefer to get the Covid‐19 vaccine. Policymakers should consider these findings when implementing successful programs. This study contributes to the literature by estimating Iranian respondents' preferences for the Covid‐19 vaccine and identifying the heterogeneity in their preferences for vaccine attributes. The findings may also inform future research and policies related to Covid‐19 vaccination programs in Iran.

Publisher

Wiley

Subject

General Medicine

Reference23 articles.

1. World Health Organization. Novel coronavirus (2019‐nCoV) situation report 1. 2020. https://apps.who.int/iris/handle/10665/330760

2. The demand for a COVID-19 vaccine in Ecuador

3. World Health Organization. Coronavirus disease 2019 (COVID‐19): weekly epidemiological update data as received by WHO from national authorities as of 24 May 2021. 2022.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

4. Contingent assessment of the COVID-19 vaccine

5. Parental Vaccine Preferences for Their Children in China: A Discrete Choice Experiment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3